Publications on Ethiqa XR:

1. Navarro et al. Lipid Bound Extended Release Buprenorphine Effectively Attenuates Post-Operative Hypersensitivity In An Incisional Pain Model In Mice (Mus Musculus). AALAS poster 2020 (Cholowat)
2. Saenz et al. Post-surgical Recovery Assessment of Mice Treated with Extended-or Sustained-release Buprenorphine. AALAS poster 2020 (Finlay)
3. Levinson et al. Pharmacokinetic and Histopathologic Study of an Extended-Release, Injectable Formulation of Buprenorphine in Sprague–Dawley Rats. JAALAS 2021 [DOI: 10.30802/AALAS-JAALAS-20-000149]4. Navarro et al. Lipid Bound Extended Release Buprenorphine (high and low doses) and Sustained Release Buprenorphine Effectively Attenuate Post-Operative Hypersensitivity in an Incisional Pain Model in Mice (Mus musculus). Anim. Models Exp. Med. 2021 [DOI: 10.1002/ame2.12157] (Cholowat)
5. Alamaw et al. Extended-release Buprenorphine, an FDA-indexed Analgesic, Attenuates Mechanical Hypersensitivity in Rats (Rattus norvegicus). JAALAS 2021 [DOI: 10.30802/AALAS-JAALAS-21-000081] (Cholowat)
6. Arthur et al. Buprenorphine Does Not Attenuate Postoperative Hypersensitivity in NSG Mice. AALAS poster 2021 (Cholowat)
7. Mangosing et al. Efficacy and Duration of Various Buprenorphine Preparations in a Mouse Hind Paw Incision Model of Pain. AALAS poster 2021 (Lieggi)
8. Alamaw et al. Extended-Release Buprenorphine, an FDA-indexed Analgesic, Attenuates Mechanical Hypersensitivity in Rats. AALAS poster 2021 (Cholowat)
9. Zhang et al. Extended Release Buprenorphine Effectively Attenuates Laser-Induced Thermal Hypersensitivity in an Incisional Model in Neonatal Rats. AALAS poster 2021 (Cholowat)
10. Saenz et al. Pharmacokinetics of Sustained-release Buprenorphine and Extended-release Buprenorphine in Mice with Surgical Catheterization. bioRxiv preprint 2022 [doi:] (Finlay)

Older publications (Animalgesic):

1. Guarnieri et al. A Long-Term Study of a Lipid-Buprenorphine Implant in Rats. J. Vet. Med. 2018 []2. Itzoe et al. Buprenorphine Analgesia in Mice. Int. J. Res. Health Sci. 2018 [DOI:10.21276/ijprhs.2018.01.15] (Guarnieri)
3. Barletta et al. The Pharmacokinetics and Analgesic Effects of Extended-Release Buprenorphine Administered Subcutaneously in Healthy Dogs. Vet. Pharmacol. Therap. 2018 [DOI: 10.1111/jvp.12497] (Messenger/Lascelles)
4. Oliver et al. Evaluation of Pain Assessment Techniques and Analgesia Efficacy in a Female Guinea Pig (Cavia porcellus) Model of Surgical Pain. JAALAS 2017 [PMCID: PMC5517332] (Lofgren)
5. Guarnieri et al. Subcutaneous Implants of a Cholesterol-Triglyceride-Buprenorphine Suspension in Rats. J. Vet. Med. 2017 []6. Sarabia-Estrada et al. Association of Nausea with Buprenorphine Analgesia for Rats. Lab Animal 2017 [] (Guarnieri)
7. Cowan et al. Lack of Adverse Effects During a Target Animal Safety Trial of Extended-Release Buprenorphine in Fischer 344 Rats. Lab Animal 2016 [DOI: 10.1038/laban.745] (Guarnieri)
8. Traul et al. Safety Studies of Post-Surgical Buprenorphine Therapy for Mice. Lab Animal 2015 [DOI: 10.1177/0023677214554216] (Guarnieri)
9. Schildhaus et al. Thermal Latency Studies in Opiate-Treated Mice. J. Pharmacy Allied Sci. 2014 [DOI: 10.4103/0975-7406.124316] (Guarnieri)